nnmt inhibitor 5-amino-1mq pharmacokinetics 5-Amino-1-MQ LABEL MISTAKES Today I noticed two major errors on a 5-Amino- 1-MQ product label — and while they may look small, they have big implications for safety, accuracy, and professionalism in the 5-Amino-1MQ 5mg & 50mg |

Point 1 in above link is about being under treated for B12 deficiency with neuro symptoms present

If you are lean and must use the thigh, always pinch the skin, use a 45-degree angle, and consider a shorter needle (3/8 inch instead of 1/2 inch) to reduce intramuscular injection risk

The first step in disposing your needles properly is to secure a puncture-proof sharps container

What are the safety risks of exceeding 100mg daily in 5-amino-1mq protocols

xvi, 257282

No human safety data : The complete absence of human clinical trials means the safety profile, side effects, optimal dosing, and pharmacokinetics in humans are entirely unknown Animal-to-human translation is uncertain : Metabolic differences between mice and humans mean that the magnitude of effects (e.g., weight loss, grip strength improvement) may not translate